Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Obeticholic Acid on Clinical Outcomes in Primary Biliary Cirrhosis
KCT0001917Phase 3Recruiting
- Sponsor
- Intercept Pharmaceuticals
- Start
- Oct 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in primary biliary cholangitis (PBC) comparing Obeticholic acid with Placebo (2 arms). Started Oct 2015; status: recruiting.
02
Drugs
obeticholic acid
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on KCT0001917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001917.